Table 2.

Univariable competing risk analysis in patients with thyroid papillary adenocarcinoma.

Variables	Gray’s test	p-Value	Cumulative incidence function
			12-months	36-months	72-months
Age	626.943	<0.0001
Sex	20.333	<0.0001
Male			0.011	0.02	0.031
Female			0.005	0.008	0.013
Marital status	35.963	<0.0001
Married			0.005	0.010	0.016
Unmarried			0.003	0.005	0.011
DSW			0.018	0.031	0.048
Race	3.387	0.336
White			0.006	0.012	0.019
Black			0.007	0.007	0.007
Asian or Pacific Islander			0.004	0.005	0.017
American Indian/Alaska Native			0.000	0.000	0.081
Stage	733.162	<0.0001
Localized			0.000	0.001	0.004
Regional			0.006	0.013	0.022
Distant			0.132	0.188	0.250
Grade	1319.580	<0.0001
Well differentiated			0.001	0.004	0.009
Moderately differentiated			0.003	0.009	0.019
Poorly differentiated			0.059	0.141	0.201
Undifferentiated			0.386	0.435	0.461
AJCC	685.372	<0.0001
I			0.000	0.001	0.003
II			0.003	0.009	0.009
III			0.004	0.005	0.013
IV			0.064	0.112	0.167
Radiation	8.937	0.003
Yes			0.007	0.014	0.024
No/unknown			0.005	0.008	0.011
Chemotherapy	1009.614	<0.0001
Yes			0.406	0.557	0.557
No/unknown			0.004	0.008	0.015
Insurance	0.450	0.503
Insured			0.006	0.011	0.019
Uninsured/unknown			0.004	0.009	0.009
Regional lymph nodes removal	10.382	0.001
Yes			0.009	0.014	0.022
No			0.001	0.005	0.012
Tumor size	224.703	<0.0001
1–10 mm			0.001	0.001	0.004
11–20 mm			0.002	0.006	0.007
21–40 mm			0.009	0.016	0.026
>40 mm			0.037	0.062	0.109

DSW – divorced, separated or widowed.